FIELD: chemistry.
SUBSTANCE: invention relates to compounds of general formula (II) and their pharmaceutically acceptable salts and stereoisomers as β2-adrenergic receptor agonists, to a pharmaceutical composition based on the said compounds, a treatment method, to a method of producing said compounds, their use, as well as to crystalline hydrochloride of N-[5-((R)-2-{2-[4-((R)-2-amino-2-phenylethylamino)phenyl]ethylamino}-1-hydroxyethyl)-2-hydroxyphenyl]formamide. The compounds can be used for treating and preventing β2-adrenergic receptor mediated diseases such as asthma and chronic obstructive pulmonary disease. In general formula (II) , R1 is NHCHO, and R2 is hydrogen; or R1 and R2, taken together, represent -NHC(=O)CH=CH- or -CH=CHC(=O)NH-; each of R5 and R6 is independently selected from hydrogen or C1-6-alkyl.
EFFECT: improved method.
14 cl, 3 dwg, 12 ex
Title | Year | Author | Number |
---|---|---|---|
ARYLALANINE DERIVATIVES AS AGONISTS OF β ADRENERGIC RECEPTOR | 2005 |
|
RU2370490C2 |
DIAMIDE COMPOUNDS POSSESSING MUSCARINIC ANTAGONIST ACTIVITY AND B2 ADRENERGIC RECEPTOR B2 AGONIST ACTIVITY | 2010 |
|
RU2543716C2 |
DIAMIDE COMPOUNDS HAVING ACTIVITY OF MUSCARINIC RECEPTOR ANTAGONIST AND ACTIVITY OF β ADRENERGIC RECEPTOR AGONIST | 2010 |
|
RU2676686C2 |
BIPHENYL DERIVATIVES | 2004 |
|
RU2330841C2 |
CRYSTALLINE FORM OF BIPHENYL COMPOUND | 2005 |
|
RU2381223C2 |
CLASS OF BIFUNCTIONAL COMPOUNDS WITH QUATERNARY AMMONIUM SALT STRUCTURE | 2017 |
|
RU2722720C1 |
BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS | 2005 |
|
RU2366656C2 |
COMBINATION OF MUSCARINE RECEPTOR ANTAGONIST AND BETA-2-ADRENORECEPTOR AGONIST | 2008 |
|
RU2460527C2 |
GUANIDINE-CONTAINING COMPOUNDS APPLICABLE AS MUSCARINIC RECEPTOR ANTAGONISTS | 2008 |
|
RU2480458C2 |
DERIVANTS OF BICYCLO[2, 2, 1] HEPT-7-YLAMINE AND THEIR APPLICATIONS | 2006 |
|
RU2442771C2 |
Authors
Dates
2010-03-27—Published
2004-09-21—Filed